-Frontline It is the goal of social revolution that connects the aam aadmi to the judiciary and to its highest institution, the Supreme Court of India. By Prof. G. MOHAN GOPAL WHAT should be the appropriate mea-sure of the relationship between the apex court of a country and its common people? Should an apex court be evaluated by who invokes its jurisdiction, from which area and for what purpose? Is an apex...
More »SEARCH RESULT
Total Matching Records found : 1209
PMO refues to give information related to Robert Vadra land deal case -Ashish Tripathi
-The Times of India LUCKNOW: The Prime Minister's Office (PMO) has denied to provide information on Robert Vadra writ petition filed in the Allahabad high court. The public information officer (PIO) of the PMO denied providing notesheet of the case-related file to the petitioner and social activist Nutan Thakur saying that the matter was sub-judice. To this Thakur, wrote to the first appellate authority (FAO) saying that the RTI Act nowhere prohibits...
More »After sexual harassment at workplace, woman faces online slander-Meena Menon
-The Hindu First it was sexual harassment at workplace. Next comes the slanderous campaign on the Internet. For this former employee of auditing firm KPMG, life has become hell since 2007. Now Aditi (name changed) is fighting with the Mumbai cyber police who are doing little on her 2012 complaint seeking action against websites which hosted offensive comments against her. Trial yet to begin While the sexual harassment case led to the...
More »Most big patented drugs skip India -Rupali Mukherjee
-The Times of India Big pharma may be crying hoarse over India's "weak'' intellectual property environment, but over the past five years or so, they have introduced only a handful of their patented blockbusters in the country. That's not all. The contribution of patented drugs in the Rs 72,000-crore pharma retail market is not even 1%, indicating that multinationals have been traditionally slow and have a poor track record in introducing...
More »Patent justice-Sakthivel Selvaraj
-The Hindu Drug patents are designed to create profits that enable more research on diseases affecting millions. But in practice, they have often generated super profits for big pharma companies while erecting access barriers for the poor. The Novartis case spotlights much that is wrong with the system. The rejection of the Novartis petition challenging one of the most progressive tenets of the Indian Patents Act (1970), as amended in 2005 by...
More »
